Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Guoda Pharmaceutical is a China-based pharmaceutical manufacturer focused on the research, production, and sale of biochemical drugs and oral formulations. The company is active and operates from Qingdao, Shandong, with licensed manufacturing for tablets, capsules, and active pharmaceutical ingredients. Public business registry sources describe a marketed portfolio including lumbrokinase enteric-coated capsules, pefloxacin mesylate capsules, procaterol hydrochloride tablets, flunarizine hydrochloride dispersible tablets, and a lumbrokinase API. The business appears to be a commercial-stage, small domestic pharma company rather than an innovation-focused clinical biotech, with emphasis on manufacturing and sales of approved products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Guoda Pharmaceutical.